Postnatal thymus transplantation with immunosuppression as treatment for DiGeorge syndrome

Blood

Volumn 104, Issue 8, 2004, Pages 2574-2581

  Markert, M Louise ^a   Alexieff, Marilyn J ^b   Li, Jie ^b   Sarzotti, Marcelle ^b   Ozaki, Daniel A ^b   Devlin, Blythe H ^b   Sedlak, Debra A ^b   Sempowski, Gregory D ^b   Hale, Laura P ^b   Rice, Henry E ^b   Mahaffey, Samuel M ^b   Skinner, Michael A ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD45 ANTIGEN; DIPHENHYDRAMINE; HLA A ANTIGEN; HLA B ANTIGEN; HLA DR ANTIGEN; METHYLPREDNISOLONE; PADGEM PROTEIN; PARACETAMOL; PHYTOHEMAGGLUTININ; T LYMPHOCYTE RECEPTOR; THYMOCYTE ANTIBODY;

ARTICLE; CLINICAL ARTICLE; DIGEORGE SYNDROME; HLA TYPING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFANT; LYMPHOCYTE PROLIFERATION; LYMPHOPOIESIS; PRIORITY JOURNAL; T LYMPHOCYTE; THYMUS TRANSPLANTATION; TREATMENT OUTCOME;

EID: 1942538141     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2003-08-2984     Document Type: Article

References (29)

1. Thomas RA, Landing BH, Wells TR. Embryologic and other developmental considerations of thirty-eight possible variants of the DiGeorge Anomaly (DGA). Am J Med Genetics. 1987;3(suppl):43-66.
2. Markert ML, Hummell DS, Rosenblatt HM, et al. Complete DiGeorge syndrome: persistence of profound immunodeficiency. J Pediatr. 1998;132: 15-21.
3. DiGeorge AM. In discussion of: Cooper MD, Peterson RDA, Good RA. A new concept of cellular basis of immunity. J Pediatr. 1965;67:907.
4. Conley ME, Beckwith JB, Mancer JFK, Tenckhoff L. The spectrum of the DiGeorge syndrome. J Pediatr. 1979;94:883-890.
5. Hong R. The DiGeorge anomaly. Immunodef Rev. 1991;3:1-14.
6. Müller W, Peter HH, Wilken M, et al. The DiGeorge syndrome, I: clinical evaluation and course of partial and complete forms of the syndrome. The DiGeorge Syndrome. Eur J Pediatr. 1988;147:496-502.
7. Ryan AK, Goodship JA, Wilson DI, et al. Spectrum of clinical features associated with interstitial chromosome 22q11 deletions: a European collaborative study. J Med Genet. 1997;34:798-804.
8. Bastian J, Law S, Vogler L, et al. Prediction of persistent immunodeficiency in the DiGeorge anomaly. J Pediatr. 1989;115:391-396.
9. Picker LJ, Treer JR, Ferguson-Darnell B, Collins PA, Buck D, Terstappen LW. Control of lymphocyte recirculation in man, I: differential regulation of the peripheral lymph node homing receptor L-selection on T cells during the virgin to memory cell transition. J Immunol. 1993;150:1105-1121.
10. Markert ML, Sarzotti M, Ozaki DA, et al. Thymic transplantation in complete DiGeorge syndrome: immunologic and safety evaluations in twelve patients. Blood. 2003:102:1121-1130.
11. Takeshita S, Toda M, Yamagishi H. Excision products of the T cell receptor gene support a progressive rearrangement model of the alpha/delta locus. EMBO J. 1989;8:3261-3270.
12. Livak F, Schatz D. T-cell receptor alpha locus V(D)J recombination by-products are abundant in thymocytes and mature T cells. Mol Cell Biol. 1996;16:609-618.
13. Kong F-k, Chen C-IH, Cooper MD. Thymic function can be accurately monitored by the level of recent T cell emigrants in the circulation. Immunity. 1998;8:97-104.
14. de Lonlay-Debeney P, Cormier-Daire V, Amiel J, et al. Features of DiGeorge syndrome and CHARGE association in five patients. J Med Genet. 1997;34:986-989.
15. Pagon RA, Graham JM, Zonana J, Yong S-L. Coloboma, congenital heart disease, and choanal atresia with multiple anomalies: CHARGE association. J Pediatr. 1981;99:223-227.
16. Lin AE, Chin AJ, Devine W, Park SC, Zackai E. The pattern of cardiovascular malformation in the CHARGE association. Am J Dis Child. 1987;141: 1010-1013.
17. Markert ML, Alexieff MJ, Jie L, et al. Complete DiGeorge syndrome: development of rash, lymphadenopathy and oligoclonal T cells in five cases. J Allergy Clin Immunol. 2004;113:733-740.
18. Dimery IW, Lee JS, Blick M, Pearson G, Spitzer G, Hong WK. Association of the Epstein-Barr virus with lymphoepithelioma of the thymus. Cancer. 1988;61:2475-2480.
19. Dictor M, Fasth A, Olling S. Abnormal B-cell proliferation associated with combined immunodeficiency, cytomegalovirus, and cultured thymus grafts. Am J Clin Pathol. 1984;82:487-490.
20. Key G, Becker MH, Baron B, et al. New Ki-67-equivalent murine monoclonal antibodies (MIB 1-3) generated against bacterially expressed parts of the Ki-67 cDNA containing three 62 base pair repetitive elements encoding for the Ki-67 epitope. Lab Invest. 1993;68:629-636.
21. Anderson P. TIA-1: structural and functional studies on a new class of cytolytic effector molecule. Curr Top Micriobiol Immunol. 1995;198:131-43.
22. Erkeller-Yuksel FM, Deneys V, Yuksel B, et al. Age-related changes in human blood lymphocyte subpopulations. J Pediatr. 1992;120:216-222.
23. de Vries E, de Bruin-Versteeg S, Comans-Bitter WM, et al. Longitudinal survey of lymphocyte subpopulations in the first year of life. Ped Res. 2000;47:528-537.
24. Driscoll DA, Budarf ML, Emanuel BS. A genetic etiology for DiGeorge syndrome: consistent deletions and microdeletions of 22q11. Am J Hum Genet. 1992;50:924-933.
25. Blake KD, Davenport SLH, Hall BD, et al. CHARGE association: an update and review for the primary pediatrician. Clin Pediatrics. 1998;37: 159-173.
26. Wang R, Martínez-Frías ML, Graham JM Jr. Infants of diabetic mothers are at increased risk for the oculo-auriculo-vertebral sequence: a case-based and case-control approach. J Pediatr. 2002;141:611-617.
27. Gosseye S, Golaire MC, Verellen G, Van Lierde M, Claus D. Association of bilateral renal agenesis and DiGeorge syndrome in an infant of a diabetic mother. Helv Paediat Acta. 1982;37:471-474.
28. Goldberg R, Motzkin B, Marion R, Scambler PJ, Shprintzen RJ. Velo-cardio-facial syndrome: a review of 120 patients. Amer J Med Genet. 1993; 45:313-319.
29. Agha IA, Rueda J, Alvarez A, et al. Short course induction immunosuppression with thymoglobulin for renal transplant recipients. Transplantation. 2002;73:473-475.